Medical Weight Loss — Newfield Health | Physician-Supervised Weight Management
Weight Loss · Physician-supervised care

Start with the biology,
not another diet

For most people who struggle with weight, the problem is not effort — it's biology. A licensed provider reviews your history and determines which oral medication option is appropriate for you.

Start your free intake →
No injections required Physician review within hours Discreet delivery
Why medical weight loss is different
✓
Diet and exercise address behavior. Medical programs address the biology driving the behavior.
✓
Hunger and cravings are not a character flaw — they are hormonal signals medication can help regulate.
✓
All options here are oral — physician review determines what's right for your profile.
About compounded medications

Some treatments described are compounded — not FDA-approved. A licensed provider determines which option is appropriate after reviewing your health history.

Board-certified physicians
Oral & non-injectable options
Licensed in all 50 states
HIPAA-compliant platform
Discreet packaging
Why it's so hard

What most people get wrong about why weight loss is hard

Most people who struggle with weight have already tried. They have counted calories, cut carbs, and done the programs. Some of it worked for a while. And then, without any single decision to stop, the weight came back.

Weight regain after caloric restriction is not a failure of willpower. It is a predictable biological response. The body fights back — lowering metabolic rate, increasing hunger hormones, reducing the sensation of fullness after meals. That is not a character issue. It is physiology.

When appetite-regulating medication works, the first thing most people describe is not weight loss. It is quiet. The food noise stops. That experience — and the biology behind it — is what medical weight loss is designed to address.

The distinction
"Behavioral intervention addresses the surface without touching the root. The hunger comes back. The metabolism slows. The body reasserts itself."
Treatment options

Three physician-reviewed pathways.
One online visit.

After your intake, a licensed provider reviews your metabolic history, BMI, comorbidities, and treatment goals to determine which approach is clinically appropriate.

Entry Tier · FDA-Approved

Metformin

The metabolic foundation — supports insulin sensitivity and blood sugar regulation. May help regulate appetite signaling through metabolic pathways.

  • FDA-approved with decades-long safety record
  • Non-injectable — oral tablet with meals
  • Appropriate for patients with metabolic risk markers
Learn More →
Provider-Reviewed · Compounded

Semaglutide Oral Suspension

GLP-1 receptor agonist that mimics fullness signals, reduces appetite, and slows gastric emptying. Compounded oral formulation.

  • Reduces appetite and food noise
  • Oral suspension — not an injection
  • Provider-reviewed for clinical appropriateness
Learn more →
⚠️ Compounded — not FDA-approved
Provider-Reviewed · Compounded

Tirzepatide ODT

Dual GIP/GLP-1 receptor agonist activating two appetite-regulating pathways. Compounded oral disintegrating tablet formulation.

  • Dual-pathway appetite regulation
  • Oral disintegrating tablet — no injection
  • Reserved for qualified candidates
Learn more →
⚠️ Compounded — not FDA-approved
How it works

What these medications
actually do

Hunger, cravings, and weight regain are not character failures — they are the outputs of hormonal and metabolic systems. Each medication addresses a different part of that biology.

Metformin
Improves insulin sensitivity — reducing the amount of insulin the body needs to manage blood sugar. Modest but meaningful metabolic support.
Semaglutide (compounded oral)
GLP-1 receptor agonist — signals fullness, slows gastric emptying, reduces appetite. Compounded formulation — not FDA-approved.
Tirzepatide (compounded ODT)
Activates both GLP-1 and GIP receptor pathways — dual mechanism. Compounded oral dosage form — no FDA-approved oral equivalent.
What to expect

Realistic expectations for medical weight loss

Weeks 1–8
Dose adjustment & appetite shift

The primary early experience is appetite change — feeling full sooner, fewer cravings, quieter food noise. GI side effects are common early and ease as the dose stabilizes.

Months 3–6
Consistent downward trend

Patients who stay engaged typically see more consistent weight reduction. Progress is not linear. Plateaus are normal.

Months 6–12+
Maintenance & sustainability

The goal shifts to a sustainable protocol that prevents old patterns from returning. Your provider will discuss long-term maintenance.

The most common reason results disappoint

Expecting medication to replace dietary and activity changes rather than support them. The mechanism works best when appetite reduction is paired with intentional dietary adjustment.

Questions

What people ask
before getting started

Is this the same as Ozempic or Wegovy?
No. Those are brand-name FDA-approved injectable semaglutide products. The semaglutide oral suspension available here is a compounded formulation — not FDA-approved.
Is this the same as Zepbound or Mounjaro?
No. Those are FDA-approved injectable tirzepatide products. The Tirzepatide ODT is a compounded oral dosage form with no FDA-approved oral equivalent.
Do I still need to change my diet?
Yes. These medications reduce hunger — they do not eliminate the need for dietary changes. Best outcomes occur when medication is paired with intentional dietary adjustment.
How much weight can I expect to lose?
Your provider will set realistic expectations based on which medication is prescribed, your metabolic profile, and your lifestyle changes. Individual results vary.
What happens if I stop treatment?
Many patients regain weight if dietary and lifestyle changes are not firmly in place. Your provider will help you plan for long-term maintenance.
Is this covered by insurance?
Most of our patients pay out of pocket. Compounded medications are typically not covered by insurance. Your provider can discuss pricing options.

Your biology has been working against you.
Now it can work with you.

For many people, the first sign that medical weight loss is working is not the scale. It is quiet. The food noise stops. The constant negotiation eases.

Start your free intake →

Important Safety Information

Metformin is FDA-approved for type 2 diabetes. Off-label use requires physician evaluation. Semaglutide oral suspension and tirzepatide ODT are compounded medications — not FDA-approved. GLP-1 medications are contraindicated in patients with personal or family history of medullary thyroid carcinoma or MEN syndrome type 2. Common side effects include nausea, vomiting, and diarrhea. This information does not constitute medical advice. Provider review required.